Shilpa Medicare's Pharma Unit-2 Acquires USFDA Inspection: Zero Observations Hike Investor Confidence

Unknown Apr 02, 2026 350 Views

Shilpa Medicare Ltd has informed the exchanges that United States Food and Drug Administration (USFDA) inspection at Shilpa Pharma Unit-2 has been successfully completed with zero observations. The development is better than the last inspection at Unit-1 which had one procedural observation last...